• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Technology
    • AI
    • History of Otolaryngology
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
    • SUO Corner
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer

by ENTtoday • June 9, 2019

  • Tweet
  • Email a link to a friend (Opens in new window) Email
Print-Friendly Version

Obtaining a history from a patient with a newly diagnosed thyroid or neck mass should include a history of taking GLP-1 drugs.

You Might Also Like

  • What Is the Treatment of the Lateral Neck in Clinically Localized Sporadic Medullary Thyroid Cancer?
  • What Is the Extent of Neck Dissection in Medullary Thyroid Carcinoma?
  • Study Raises Concern over Imaging after Thyroid Cancer
  • Management Issues in Recurrent and Metastatic Thyroid Cancer
Explore This Issue
June 2019

Implications for Practice

While it is unlikely that otolaryngologists will be prescribing GLP-1 medications, it is likely that they will see patients using these drugs or be referred patients who develop neck masses. Obtaining a history from a patient with a newly diagnosed thyroid or neck mass should include a history of taking GLP-1 drugs. Our patients with MTC or those who are family members of patients with MTC should not be taking these medications at this time due to the risk. An awareness and knowledge of this adverse effect are necessary.

David Myssiorek, MD
Department of Otolaryngology Head and Neck Surgery
Bronxcare Health System
Bronx, NY

Vivien Leung, MD
Department of Endocrinology
Bronxcare Health System
Bronx, NY

Pages: 1 2 | Single Page

Filed Under: Features, Head and Neck, Practice Focus, Viewpoints Tagged With: thyroid cancerIssue: June 2019

You Might Also Like:

  • What Is the Treatment of the Lateral Neck in Clinically Localized Sporadic Medullary Thyroid Cancer?
  • What Is the Extent of Neck Dissection in Medullary Thyroid Carcinoma?
  • Study Raises Concern over Imaging after Thyroid Cancer
  • Management Issues in Recurrent and Metastatic Thyroid Cancer

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you think GLP-1s are the next big disruptors in ENT practice?

View Results

Loading ...
  • Polls Archive

Top Articles for Residents

  • The Example We Set: Thoughts on the End of Residency Training
  • Is the SLOR in Otolaryngology Residency Applications Contributing to Rural Disparities?
  • Applications Open for Resident Members of the ENTtoday Editorial Board: Deadline Extended
  • A Resident’s View of AI in Otolaryngology
  • Call for Resident Bowl Questions
  • Popular this Week
  • Most Popular
  • Most Recent
    • How GLP-1s Are Changing Otolaryngology Practice
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • History of the Cochlear Implant
    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment
    • Complications for When Physicians Change a Maiden Name
    • Facial Nerve Paralysis: Protecting the Eye and Restoring Function
    • Multi-Institutional Validation of the Interarytenoid Assessment Protocol for Pediatric Laryngeal Cleft
    • DB-OTO Gene Therapy for Inherited Deafness
    • Wearable AR for Nystagmus Examination in Patients with Vertigo: Randomized Crossover Usability Study
    • Increased Prevalence of Hearing Loss and Tinnitus in Patients with Retinal Vein Occlusion

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939